CDEK by Data4ThePeople
Sign in Sign up
← All drugs Report issue

oh2

Biologicalexperimental

Clinical trial activity

11 trials · 2 clinical orgs · 0 marketing orgs

Phase 1
8
Phase 2
8
Phase 3
1
Phase 4
0

Earliest trial started Apr 2, 2019 (NCT03866525)

Timeline

2010s

  1. Jan 1, 2019

    Earliest Phase 1 Sponsor(trial)

2020s

  1. Jan 1, 2022

    Earliest Phase 2 Sponsor(trial)

  2. Jan 1, 2023

    Earliest Phase 3 Sponsor(trial)

Indications

Studied for

Mechanism of action

Chemistry & pharmacology

Oral

No

Parenteral

No

Topical

No

Clinical trials

NCT IDPhaseStart dateSponsor(s)
NCT05954091Phase 1Sep 1, 2023Binhui Biopharmaceutical Co., Ltd.
NCT05698459Phase 1May 5, 2023Binhui Biopharmaceutical Co., Ltd.
NCT05868707Phase 3Mar 8, 2023Binhui Biopharmaceutical Co., Ltd.
NCT05648006Phase 2Dec 31, 2022Wuhan Binhui Biotechnology Co., Ltd.
NCT05232136Phase 1/Phase 2 (Phase 2)Jul 11, 2022Wuhan Binhui Biotechnology Co., Ltd.
NCT05248789Phase 2May 25, 2022Wuhan Binhui Biotechnology Co., Ltd.
NCT05235074Phase 1/Phase 2 (Phase 2)Nov 16, 2021Wuhan Binhui Biotechnology Co., Ltd.
NCT04616443Phase 1/Phase 2 (Phase 2)Dec 1, 2020Wuhan Binhui Biotechnology Co., Ltd.
NCT04637698Phase 1/Phase 2 (Phase 2)Nov 30, 2020Wuhan Binhui Biotechnology Co., Ltd.
NCT04386967Phase 1/Phase 2 (Phase 2)Mar 13, 2020Wuhan Binhui Biotechnology Co., Ltd.
NCT03866525Phase 1Apr 2, 2019Wuhan Binhui Biotechnology Co., Ltd.
Showing 11 of 11 trials
Page 1 / 1

Organizations

Research & Development (2)

OrganizationOrg typeTrialsAs lead sponsorPhasesEarliest year
Wuhan Binhui Biotechnology Co., Ltd.For profit8822019
Binhui Biopharmaceutical Co., Ltd.For profit3322023
2 organizations
Page 1 / 1